Publications from OUS - Melanoma research group

34 publications found

1. Skaara TR, Amdal CD, Jespersen H, Namtvedt SK (2025)
   Kolestase etter bruk av fenbendazol som alternativ behandling mot kreft
   145 (12)
   DOI 10.4045/tidsskr.25.0229, PubMed 41097960
2. Fager A, Samuelsson M, Olofsson Bagge R, Pivodic A, Bjursten S, Levin M, Jespersen H, Ny L (2025)
   Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases
   3 (1), 22
   DOI 10.1038/s44276-025-00137-2, PubMed 40217072
3. Eide NA, Noer A, Jespersen H, Jebsen P, Geisler J (2024)
   Delayed Distant Recurrence of a Uveal Melanoma 4 Decades after Enucleation
   17 (1), 1131-1139
   DOI 10.1159/000541341, PubMed 39474560
4. Frich L, Hermann R, Ryder T (2024)
   Breast implant-associated anaplastic large cell lymphoma
   144 (12)
   DOI 10.4045/tidsskr.24.0315, PubMed 39404238
5. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2023)
   Erratum: "MRI pulse sequence integration for deep-learning-based brain metastases segmentation"
   50 (8), 5294
   DOI 10.1002/mp.16594, PubMed 37573581
6. Bartula I, Tran AD, Nowak AK, Ahmed T, Morton RL, Burmeister BH, Dolven-Jacobsen K, Nobes J, Thompson JF, Fogarty GB, Lo SN, Hong AM (2023)
   Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
   41, 100597
   DOI 10.1016/j.ctro.2023.100597, PubMed 37441544
7. Sah VR, Jespersen H, Karlsson J, Nilsson LM, Bergqvist M, Johansson I, Carneiro A, Helgadottir H, Levin M, Ullenhag G, Ståhlberg A, Olofsson Bagge R, Nilsson JA, Ny L (2023)
   Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
   3 (5), 884-895
   DOI 10.1158/2767-9764.CRC-22-0490, PubMed 37377898
8. Winge-Main A, Robsahm TE, Nyakas M, Festervoll G, Torkilseng E, Thybo S, Pati S, Carroll R (2023)
   Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway
   19 (3), 205-215
   DOI 10.2217/fon-2022-0969, PubMed 36974621
9. Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Bjørnerud A, Zaharchuk G, Grøvik E (2023)
   2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
   16, 1056068
   DOI 10.3389/fninf.2022.1056068, PubMed 36743439
10. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
    Correction: Melanoma - investigation and primary treatment
    142 (1)
    DOI 10.4045/tidsskr.22.0806, PubMed 36655962
11. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
    Melanoma - investigation and primary treatment
    142 (15)
    DOI 10.4045/tidsskr.22.0043, PubMed 36286571
12. Jespersen H (2022)
    Moles and melanoma
    142 (15)
    DOI 10.4045/tidsskr.22.0626, PubMed 36286558
13. Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022)
    Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
    7 (5), 100588
    DOI 10.1016/j.esmoop.2022.100588, PubMed 36116420
14. Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK (2021)
    Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
    150 (1), 100-111
    DOI 10.1002/ijc.33768, PubMed 34449877
15. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2021)
    MRI pulse sequence integration for deep-learning-based brain metastases segmentation
    48 (10), 6020-6035
    DOI 10.1002/mp.15136, PubMed 34405896
16. Heck A, Winge-Main AK (2021)
    Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
    14 (5)
    DOI 10.1136/bcr-2021-241981, PubMed 34045201
17. Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
    Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
    4 (1), 33
    DOI 10.1038/s41746-021-00398-4, PubMed 33619361
18. Digernes I, Nilsen LB, Grøvik E, Bjørnerud A, Løvland G, Vik-Mo E, Meling TR, Saxhaug C, Helland Å, Jacobsen KD, Geier O, Emblem KE (2020)
    Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
    65 (22), 225020
    DOI 10.1088/1361-6560/abb71a, PubMed 33200748
19. Nilsen LB, Digernes I, Grøvik E, Saxhaug C, Latysheva A, Geier O, Breivik B, Sætre DO, Jacobsen KD, Helland Å, Emblem KE (2020)
    Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
    2 (1), vdaa028
    DOI 10.1093/noajnl/vdaa028, PubMed 32642687
20. Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
    Soluble AXL as a marker of disease progression and survival in melanoma
    15 (1), e0227187
    DOI 10.1371/journal.pone.0227187, PubMed 31917795
21. Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, Vardy JL, Nowak AK, Dhillon HM, Ahmed T, Shivalingam B, Long GV, Menzies AM, Hruby G, Drummond KJ, Mandel C, Middleton MR, Reisse CH, Paton EJ, Steel V, Williams NC, Scolyer RA, Morton RL, Thompson JF (2019)
    Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
    37 (33), 3132-3141
    DOI 10.1200/JCO.19.01414, PubMed 31553661
22. Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T (2019)
    Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
    197 (1), 74-82
    DOI 10.1111/cei.13283, PubMed 30821848
23. Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE (2018)
    Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
    3 (4), 559-567
    DOI 10.1016/j.adro.2018.05.005, PubMed 30370356
24. Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
    Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
    79 (1), 118-125.e1
    DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861
25. Fogarty GB, Hong A, Dolven-Jacobsen K, Reisse CH, Burmeister B, Haydu LH, Dhillon H, Steel V, Shivalingam B, Drummond K, Vardy J, Nowak A, Hruby G, Scolyer RA, Mandel C, Thompson JF (2015)
    First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
    8, 192
    DOI 10.1186/s13104-015-1153-5, PubMed 25952979
26. Fogarty GB, Hong A, Jacobsen KD, Reisse CH, Shivalingam B, Burmeister B, Haydu LE, Paton E, Thompson JF (2014)
    Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
    7, 412
    DOI 10.1186/1756-0500-7-412, PubMed 24981506
27. Hong AM, Suo C, Valenzuela M, Haydu LE, Jacobsen KD, Reisse CH, Fogarty G (2014)
    Low incidence of melanoma brain metastasis in the hippocampus
    111 (1), 59-62
    DOI 10.1016/j.radonc.2014.01.012, PubMed 24560764
28. Geisler J, Bachmann IM, Nyakas M, Helsing P, Fjøsne HE, Mæhle LO, Aamdal S, Eide NA, Svendsen HL, Straume O, Robsahm TE, Jacobsen KD, Akslen LA (2013)
    Malignant melanoma--diagnosis, treatment and follow-up in Norway
    133 (20), 2154-9
    DOI 10.4045/tidsskr.12.1416, PubMed 24172628
29. Jacobsen KD, Tausjø J, Hager B, Gundersen S (2010)
    [Treatment of metastatic malignant melanoma localized to an extremity]
    130 (1), 21-4
    DOI 10.4045/tidsskr.09.0701, PubMed 20094118
30. Jacobsen KD, Fosså SD, Aamdal S (2006)
    [Malignant melanoma--diagnosis and treatment]
    126 (23), 3094-7
    PubMed 17160112
31. Jacobsen KD, Fosså SD, Bjøro TP, Aass N, Heilo A, Stenwig AE (2002)
    Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
    42 (3), 229-38; discussion 237-8
    DOI 10.1016/s0302-2838(02)00274-9, PubMed 12234507
32. Jacobsen KD, Theodorsen L, Fossa SD (2001)
    Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
    165 (1), 93-6
    DOI 10.1097/00005392-200101000-00023, PubMed 11125372
33. Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
    A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
    193 (7), 471-8
    DOI 10.1016/s0344-0338(97)80099-4, PubMed 9342752
34. Jacobsen KD, Olsen DR, Fosså K, Fosså SD (1997)
    External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis
    38 (1), 95-102
    DOI 10.1016/s0360-3016(96)00597-4, PubMed 9212009